Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma

BACKGROUND: While sentinel lymph node (SLN) biopsy is a standard procedure used to identify patients at risk for melanoma recurrence, it fails to accurately risk stratify certain patients. Since processes in SLNs regulate anti-tumor immune responses, we hypothesize that SLN gene expression may be us...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Surg Oncol
Päätekijät: Farrow, Norma E, Holl, Eda K, Jung, Jeanne, Gao, Junheng, Jung, Sin-Ho, Al-Rohil, Rami N, Selim, Maria A, Mosca, Paul J, Ollila, David W, Antonia, Scott J, Tyler, Douglas S, Nair, Smita K, Beasley, Georgia M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126577/
https://ncbi.nlm.nih.gov/pubmed/33205334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-09277-w
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia